A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment.
about
CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage responseActions of aprataxin in multiple DNA repair pathwaysAPLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaksAprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate endsAprataxin forms a discrete branch in the HIT (histidine triad) superfamily of proteins with both DNA/RNA binding and nucleotide hydrolase activitiesSpecific recognition of a multiply phosphorylated motif in the DNA repair scaffold XRCC1 by the FHA domain of human PNKEukaryotic DNA ligases: structural and functional insightsMolecular mechanism of DNA deadenylation by the neurological disease protein aprataxinXRCC1 is required for DNA single-strand break repair in human cells.XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damageOverview of base excision repair biochemistryOxidation state of the XRCC1 N-terminal domain regulates DNA polymerase binding affinityThe structural basis for partitioning of the XRCC1/DNA ligase III- BRCT-mediated dimer complexesThe role of ADP-ribosylation in regulating DNA interstrand crosslink repairRegulation of NuA4 histone acetyltransferase activity in transcription and DNA repair by phosphorylation of histone H4.Base Excision Repair, a Pathway Regulated by Posttranslational ModificationsThe structural basis of XRCC1-mediated DNA repairX-ray repair cross complementing protein 1 in base excision repair.Structure and identification of ADP-ribose recognition motifs of APLF and role in the DNA damage response.XRCC1 coordinates disparate responses and multiprotein repair complexes depending on the nature and context of the DNA damagePol β associated complex and base excision repair factors in mouse fibroblasts.Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitorsStructure and function of the DNA ligases encoded by the mammalian LIG3 gene.DNA repair mechanisms in dividing and non-dividing cells.Aprataxin localizes to mitochondria and preserves mitochondrial functionRecognition and repair of chemically heterogeneous structures at DNA endsTidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair.Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.Phosphorylation-regulated binding of Ctp1 to Nbs1 is critical for repair of DNA double-strand breaksATM mediates oxidative stress-induced dephosphorylation of DNA ligase IIIalpha.New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins.Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease.Human base excision repair complex is physically associated to DNA replication and cell cycle regulatory proteinsQuantitative characterization of protein-protein complexes involved in base excision DNA repairThe region of XRCC1 which harbours the three most common nonsynonymous polymorphic variants, is essential for the scaffolding function of XRCC1Slow mitochondrial repair of 5'-AMP renders mtDNA susceptible to damage in APTX deficient cells.JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combination.Structural basis for phosphorylation-dependent signaling in the DNA-damage response.
P2860
Q22001526-F4B84E2A-C428-44A6-826F-527AB8027116Q24295253-CF137C3E-C2CE-4D89-8198-0924EAB8ADCDQ24299831-CDD8F8F0-3F2A-4EB1-9059-7FA8B1459B07Q24306648-EDF2072C-20D3-4224-944D-898E0546A73DQ24308872-4EB500DE-5B3B-4148-BF43-9B2C6365698FQ24318721-DE6A825A-0E58-491D-8A5E-52194A345743Q24617266-B205EBE3-A5FA-4388-855A-46969195917DQ24651265-27C18B2D-A0EE-440C-9BD5-BD6D556C01E2Q24796404-10DEB9B8-FCDC-4DA8-8589-55F943493D78Q25257391-3BB6250C-4095-4083-B1D6-3DE392668684Q27021659-580943BF-D6E1-47F8-BBBB-8C13F6148AFBQ27660365-BFBCD2E6-DC74-4800-BE92-51E2204F31F1Q27666268-64552D00-182D-4ECE-8390-01A76CC6E54AQ27727978-BD88C275-A891-45A5-A704-E940A4D941DAQ27931428-ECD69DED-9DE5-42B2-862D-4F0C68D2E1E1Q28078441-51ADE84B-AC15-4232-9634-C8BECA722284Q28259282-C75CA071-2047-40C6-A08C-A34EFBF96B2CQ30458938-25C2EB3C-FBD5-477D-98CB-F2DDAE1A65E8Q33927202-D7D78982-08F5-4027-9087-5C3D0833C7D6Q33970153-749B01B4-5E12-43F8-A408-A3B414B3826DQ34033880-370869CC-EE47-4FC8-9506-0F74A16F5D26Q34110442-E84A4707-4170-4C04-B2E7-8CDF3A5E9329Q34231660-7C0F5DB8-5247-4F4B-9D97-EA914CB887A8Q34369324-C5FE1350-9BD1-4141-BCCF-EB0DFFCFF042Q34727858-7EEA7C3C-432A-4D56-AFE0-6655E46394E2Q34937780-6C2ECC8A-F62E-4D6F-B2C9-574130E51DF7Q35002075-4905B9CD-714F-41D5-9C06-F1D886466E5EQ35099098-C819CDFD-5F93-44CB-9E0A-FB6422C77493Q35112912-220AB367-6BEC-4B2E-8D75-90996037A19AQ35160570-4ABAF1FA-EF0E-42F0-9475-9E256B4EFC22Q35215475-304B3B4F-4B2D-41C4-9A38-07DF071E7CE0Q35395549-85421C24-D301-4D27-AF1B-D31E2E2AF852Q35562885-4CFB304E-4226-45C5-9BA2-9EE9EE0D0E66Q35781797-FF74F83B-0942-46F1-A969-85A7461DF497Q35842555-4EE8F596-D2D1-43E4-A481-11220D534A1EQ35869467-D3A9321E-8EA8-4171-973A-44A7DC5C1B09Q35932925-C648B121-E53B-4A0C-A190-2F1C7AB9632DQ36291991-7C1253BC-B1FA-4704-BA8B-FAFAB14256A6Q36294441-6EAA8A53-A631-49C1-9CD7-5C5C5D4FDCEDQ36333360-3286C34F-F294-40EB-BE30-CC2EEA9558B3
P2860
A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@ast
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@en
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@nl
type
label
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@ast
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@en
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@nl
prefLabel
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@ast
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@en
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@nl
P2093
P2860
P1476
A new XRCC1-containing complex ...... yl methanesulfonate treatment.
@en
P2093
Benjamin Ping-Chi Chen
David Chen
Doug W Chan
Jung-Jung Mu
Maria Rodriguez
P2860
P304
P356
10.1128/MCB.24.19.8356-8365.2004
P407
P577
2004-10-01T00:00:00Z